
StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet
GlucoBalance Trio (Glimepiride/Metformin/Pioglitazone 2mg/500mg/15mg) tablets offer a combined approach to managing elevated blood sugar. This medication, used alongside a healthy diet and regular exercise, assists adults with type 2 diabetes in achieving better glycemic control. It enhances insulin effectiveness, consequently reducing blood glucose levels. Always adhere to your doctor's prescribed dosage and frequency for GlucoBalance Trio. Take it with food to minimize potential stomach discomfort. If you miss a dose, take it promptly, unless your next dose is imminent; in that case, skip the missed dose and resume your usual schedule. Never double the dose. Overdosage can result in dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects can include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your physician before starting GlucoBalance Trio if you have kidney, liver, or heart issues, or if you are pregnant or breastfeeding. Your doctor will assess your kidney function prior to treatment. Limit alcohol consumption while taking this medication to lessen the risk of side effects.
Uses of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet
Managing Type 2 diabetes
Major Benefits of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet should be administered with food.
Common Side effects of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet should be administered with food.
How StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet works:
StayHappi's combined tablet, containing 2mg glimepiride, 500mg metformin, and 15mg pioglitazone, offers a triple-action approach to diabetes management. This formulation unites three distinct antidiabetic agents – glimepiride (a sulfonylurea), metformin (a biguanide), and pioglitazone (a thiazolidinedione) – to enhance blood sugar control when single or dual drug regimens prove inadequate. Glimepiride stimulates pancreatic insulin release to reduce blood glucose. Metformin acts on multiple fronts: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone complements this action by further boosting insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a fetus. A physician will assess the advantages against potential risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg tablets cautiously, potentially requiring dose modification. Medical advice is necessary. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet :
Should you forget a dose of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
